1.
PET imaging of [11C]PBR28 in Parkinson’s disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding
by Varnäs, Katarina
European journal of nuclear medicine and molecular imaging, 2018, Vol.46 (2), p.367-375
2.
Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study
by Rodriguez-Vieitez, Elena
European journal of nuclear medicine and molecular imaging, 2015, Vol.42 (7), p.1119-1132
3.
Application of cross-species PET imaging to assess neurotransmitter release in brain
by Finnema, Sjoerd J
Psychopharmacology, 2015, Vol.232 (21-22), p.4129-4157
4.
Dual tracer tau PET imaging reveals different molecular targets for 11C-THK5351 and 11C-PBB3 in the Alzheimer brain
by Chiotis, Konstantinos
European journal of nuclear medicine and molecular imaging, 2018, Vol.45 (9), p.1605-1617
5.
Positron emission tomography measurement of brain MAO-B inhibition in patients with Alzheimer’s disease and elderly controls after oral administration of sembragiline
by Sturm, Stefan
European journal of nuclear medicine and molecular imaging, 2016, Vol.44 (3), p.382-391
6.
Guidelines to PET measurements of the target occupancy in the brain for drug development
by Takano, Akihiro
European journal of nuclear medicine and molecular imaging, 2016, Vol.43 (12), p.2255-2262
7.
Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT
by Varrone, Andrea
European journal of nuclear medicine and molecular imaging, 2009, Vol.36 (10), p.1639-1650
8.
SERT and NET occupancy by venlafaxine and milnacipran in nonhuman primates: a PET study
by Takano, Akihiro
Psychopharmacology, 2012, Vol.226 (1), p.147-153
9.
Detection of amyloid in Alzheimer’s disease with positron emission tomography using [11C]AZD2184
by Nyberg, Svante
European journal of nuclear medicine and molecular imaging, 2009, Vol.36 (11), p.1859-1863
10.
Characterization of [11C]Lu AE92686 as a PET radioligand for phosphodiesterase 10A in the nonhuman primate brain
by Yang, Kai-Chun
European journal of nuclear medicine and molecular imaging, 2016, Vol.44 (2), p.308-320
11.
GABAA receptor occupancy by subtype selective GABAAα2,3 modulators: PET studies in humans
by Jucaite, Aurelija
Psychopharmacology, 2016, Vol.234 (4), p.707-716
12.
In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer’s disease patients
by Varrone, Andrea
European journal of nuclear medicine and molecular imaging, 2013, Vol.40 (6), p.921-931
13.
Serotonin transporter occupancy by escitalopram and citalopram in the non-human primate brain: a [11C]MADAM PET study
by Finnema, Sjoerd J
Psychopharmacology, 2015, Vol.232 (21-22), p.4159-4167
14.
Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer’s disease patients and control subjects
by Varrone, Andrea
European journal of nuclear medicine and molecular imaging, 2014, Vol.42 (3), p.438-446
15.
Guideline to regulations for radiopharmaceuticals in early phase clinical trials in the EU
by Verbruggen, Alfons
European Journal of Nuclear Medicine, 2008, Vol.35 (11), p.2144-2151
16.
EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD)
by Todde, Sergio
European journal of nuclear medicine and molecular imaging, 2014, Vol.41 (11), p.2175-2185
17.
NET occupancy by clomipramine and its active metabolite, desmethylclomipramine, in non-human primates in vivo
by Takano, Akihiro
Psychopharmacologia, 2011, Vol.216 (2), p.279-286
18.
A PET study on regional coexpression of 5-HT1A receptors and 5-HTT in the human brain
by LUNDBERG, Johan
Psychopharmacologia, 2007, Vol.195 (3), p.425-433
19.
Radiopharmaceuticals for positron emission tomography investigations of Alzheimer’s disease
by Någren, Kjell
European journal of nuclear medicine and molecular imaging, 2009, Vol.37 (8), p.1575-1593
20.
Improved mapping and quantification of serotonin transporter availability in the human brainstem with the HRRT
by Schain, Martin
European journal of nuclear medicine and molecular imaging, 2012, Vol.40 (2), p.228-237
